South Tees Hospitals NHS Foundation Trust continue to build on their successful record for patient-centred research, development and innovation by leading a pioneering trial which could, ultimately, be used as a first line to detect osteoporosis. In their latest partnership with IBEX Innovations Limited (IBEX), €1.6million has been secured from the European Union’s Horizon 2020 research and innovation programme to investigate the effectiveness of their equipment, which can pick up bone density information alongside conventional X-ray images.
A surgeon-led clinic for people with a neck lump and immediate access to CT scans are amongst the new developments at Teesside’s biggest hospital, which could help speed up the diagnosis of head and neck cancers. A wide variety of specialists including radiologists, pathologists, ear nose and throat specialists and the Oral MaxilloFacial specialists worked together on the potential solutions to provide access to quicker diagnosis and treatment during an innovative workshop at South Tees Institute of Learning, Research and Innovation (LRI), on The James Cook University Hospital site.
A massive “thank you” is being issued to 3,457 patients and more than 200 staff, after South Tees Hospitals NHS Foundation Trust enjoyed a record year in Research & Development. The year 2016 to 2017 became South Tees Hospitals NHS Foundation Trust’s most successful in R&D to date, as the Trust boasted a 17% increase in the number of patients taking part in clinical trials compared with the previous year.
A County Durham woman who has been battling ovarian cancer for more than five years has become the first in the UK to benefit from a new drug to prevent a recurrence of the disease. The 46-year-old, who does not want to be named, is a patient of Dr Talal Mansy, a consultant medical oncologist at The James Cook University Hospital in Middlesbrough.
A determined grandad who is battling prostate cancer has spoken of his joy at joining Jeff Stelling on his March for Men walk – and vowed to get involved with the event again next year. Roofer Ken Bashford, 60, of New Marske, walked with Jeff Stelling and other Prostate Cancer UK fundraisers from Middlesbrough FC’s Riverside Stadium to the Transporter Bridge, as part of Sky Soccer Saturday anchor’s effort to complete 15 marathons in 15 days, taking in 40 football stadiums across the country, from Exeter City FC to Newcastle United.
When self-employed roofer and proud grandad Ken Bashford received an email from Prostate Cancer UK inviting him to take part in local celebrity Jeff Stelling’s latest marathon effort to fight the disease, he was “over the moon”. It was a much-welcomed high point in what has been a rollercoaster ride for the 60-year-old, from Marske, since being diagnosed with prostate cancer himself following a simple blood test in May 2015.
Pancreatic Cancer UK is encouraging people with advanced pancreatic cancer in Middlesbrough to find out more about a pioneering clinical trial at The James Cook University Hospital, which is offering a new combination of treatments which could ultimately allow patients to live for longer. The new HALO 301 trial could offer patients with pancreatic cancer that has spread outside the pancreas, a potential new treatment option for a disease which currently has very few treatments.
Cardiologists at Teesside’s biggest hospital have been praised for their role in a major international study looking at the effectiveness of different treatments for patients with Ischemic Heart Disease (IHD).
The cardiothoracic team, led by Dr Mark de Belder at The James Cook University Hospital, were praised by New York University-based leaders of the ISCHEMIA trial, a major international, multicentre randomised trial researching the best way to manage the condition.
A successful project to provide intravenous (IV) antibiotics to patients with a long-term lung condition in their own homes is set to benefit dozens of others with different health conditions. The cutting-edge service improvement enterprise looked at how providing IV antibiotic therapy to patients in their own homes rather than as inpatients in hospital could improve both the patient experience and also reduce costs.